Plain-English translation of NCT05914987 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Neoplasms research guide →This study is looking at how well personalized cancer treatments work for people with pancreatic cancer. Researchers will review your medical records and tumor test results to understand whether matching a patient's specific tumor characteristics to a treatment plan leads to better outcomes. The goal is to learn if this personalized approach helps patients live longer and tolerate treatment better.
Pancreatic cancer is very serious, and standard treatments don't work the same way for everyone. Doctors now have the ability to test tumors to find their unique characteristics, but we don't yet fully understand how well using this information to pick a personalized treatment actually helps patients in real life.
You likely qualify if…
You likely don't qualify if…
This is not a treatment study — you will continue receiving whatever cancer care your doctors recommend. Instead, researchers will review your medical records (past and future) to collect information about your tumor tests, which treatments you received, and how well those treatments worked for you. You do not need to attend special study visits or take any study medication; the study simply tracks what happens with your standard medical care.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
United States
Enrollment target
~1,000 participants
Started
December 2023
Primary completion
August 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cancer Center Clinical Trials Office
Medical College of Wisconsin
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.